Cannabis investors are exercising caution, with some stocks experiencing significant declines over the past three months. The outlook for the industry is being shaped by various factors, including earnings and cash positions, as well as potential regulatory changes. Investment in the cannabis market appears to be muted, despite some signs of momentum and maturation in certain sectors, such as europe's pharmaceuticals market.